| 000 | 01646 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518051223.0 | ||
| 264 | 0 | _c20200127 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood.2019000904 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVogiatzi, Fotini | |
| 245 | 0 | 0 |
_aDaratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bBlood _c08 2019 |
||
| 300 |
_a713-716 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasm, Residual _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWinterberg, Dorothee | |
| 700 | 1 | _aLenk, Lennart | |
| 700 | 1 | _aBuchmann, Swantje | |
| 700 | 1 | _aCario, Gunnar | |
| 700 | 1 | _aSchrappe, Martin | |
| 700 | 1 | _aPeipp, Matthias | |
| 700 | 1 | _aRichter-Pechanska, Paulina | |
| 700 | 1 | _aKulozik, Andreas E | |
| 700 | 1 | _aLentes, Jana | |
| 700 | 1 | _aBergmann, Anke K | |
| 700 | 1 | _aValerius, Thomas | |
| 700 | 1 | _aFrielitz, Fabian-Simon | |
| 700 | 1 | _aKellner, Christian | |
| 700 | 1 | _aSchewe, Denis M | |
| 773 | 0 |
_tBlood _gvol. 134 _gno. 8 _gp. 713-716 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.2019000904 _zAvailable from publisher's website |
| 999 |
_c29907303 _d29907303 |
||